Business Context and Reporting Period
This Form 8-K is a current report filed by OSR Health, Inc. on July 31, 2026. The filing addresses a specific regulatory communication regarding the Company's Shareholder Loyalty Contingent Value Rights (CVR) program.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory disclosure and does not contain financial statement data.
Material Changes
The material event reported is a verbal communication from The Nasdaq Stock Market LLC received on July 31, 2026. Nasdaq confirmed that the Company's CVR program will not result in any mechanical adjustment to the price of the Company's common stock, either upon the distribution of the CVRs or upon the delivery of additional shares to enrolled holders.
Guidance, Outlook, and Risks
- Management Commentary: The Company clarified that Nasdaq's position relates solely to price-adjustment treatment for the CVR distribution and share deliveries.
- Limitations: The communication does not constitute an endorsement of the CVR program or an investment in the Company's securities.
- Regulatory Status: The filing notes that separate securities-law requirements applicable to the distribution of CVRs and share delivery remain subject to the Company's ongoing regulatory process.
Investor Verification Checklist
- Verify the status of the ongoing regulatory process for the CVR distribution as mentioned in the filing.
- Review the full text of the press release (Exhibit 99.1) for details on the CVR program mechanics.
- Confirm that the Nasdaq communication does not alter the Company's compliance obligations under other securities laws.